GI
MRTX

GAMCO Investors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

GAMCO Investors’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-36,100
Closed -$2.12M – 890
2023
Q4 		$2.12M Buy
+36,100
New +$2.03M 0.02% 486

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

GAMCO Investors's MRTX Position: Q1 2024 in Review

GAMCO Investors sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 36,100 shares — an estimated $2.12M sold.

GAMCO Investors first reported a position in MRTX in Q4 2023 and held it in 1 quarter. The position peaked at $2.12M in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • GAMCO Investors reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • GAMCO Investors sold 36,100 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.12M.
  • GAMCO Investors first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • GAMCO Investors's Mirati Therapeutics, Inc. Common Stock position peaked at $2.12M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on GAMCO Investors's 13F filing for Q1 2024, filed 14 May 2024.